NOACs;朋友还是敌人?

L. Rasmussen
{"title":"NOACs;朋友还是敌人?","authors":"L. Rasmussen","doi":"10.4172/2155-9864.1000323","DOIUrl":null,"url":null,"abstract":"New oral anticoagulants (NOAC’s) are becoming more popular as antithrombotic agents for the prevention of venous thromboembolism in atrial fibrillation and as prophylaxis in hip and knee surgery. With simple administration, rapid onset, few drug interactions and the absence of coagulation monitoring, NOAC’s appear as a friend in the prevention of thromboembolic events. Undoubtedly patients would prefer treatment with a simple pill over injections and intensive monitoring implied that the treatment is efficient and without adverse effects.","PeriodicalId":182392,"journal":{"name":"Journal of Blood Disorders and Transfusion","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"NOACs; Friend or Foe?\",\"authors\":\"L. Rasmussen\",\"doi\":\"10.4172/2155-9864.1000323\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"New oral anticoagulants (NOAC’s) are becoming more popular as antithrombotic agents for the prevention of venous thromboembolism in atrial fibrillation and as prophylaxis in hip and knee surgery. With simple administration, rapid onset, few drug interactions and the absence of coagulation monitoring, NOAC’s appear as a friend in the prevention of thromboembolic events. Undoubtedly patients would prefer treatment with a simple pill over injections and intensive monitoring implied that the treatment is efficient and without adverse effects.\",\"PeriodicalId\":182392,\"journal\":{\"name\":\"Journal of Blood Disorders and Transfusion\",\"volume\":\"13 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-11-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Blood Disorders and Transfusion\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2155-9864.1000323\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Blood Disorders and Transfusion","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2155-9864.1000323","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

新型口服抗凝剂(NOAC’s)作为抗血栓药物越来越受欢迎,用于预防房颤的静脉血栓栓塞和髋关节和膝关节手术的预防。NOAC给药简单,起效快,药物相互作用少,无需凝血监测,在预防血栓栓塞事件中发挥着重要作用。毫无疑问,患者更喜欢简单的药丸治疗,而不是注射,而严密的监测意味着治疗是有效的,没有副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
NOACs; Friend or Foe?
New oral anticoagulants (NOAC’s) are becoming more popular as antithrombotic agents for the prevention of venous thromboembolism in atrial fibrillation and as prophylaxis in hip and knee surgery. With simple administration, rapid onset, few drug interactions and the absence of coagulation monitoring, NOAC’s appear as a friend in the prevention of thromboembolic events. Undoubtedly patients would prefer treatment with a simple pill over injections and intensive monitoring implied that the treatment is efficient and without adverse effects.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信